• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Three-Class Antiretroviral Therapy for HIV Not Appropriate: Results from the FIRST Study

  • — 19 Jan, 2007
AudioMedica News
AudioMedica News
Three-Class Antiretroviral Therapy for HIV Not Appropriate: Results from the FIRST Study
Three-Class Antiretroviral Therapy for HIV Not Appropriate: Results from the FIRST Study
00:00 /
RSS Feed
Share
Link
Embed
Rodger MacArthur

RODGER MACARTHUR, Wayne State University, Detroit

REFERENCE: Lancet 2006; 368: 2125-35
A three-class HIV antiretroviral therapy is not necessary, according to data published in the Lancet. The FIRST study had three arms which included non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), or both, all in the presence of nucleoside reverse transcriptase inhibitors. Derek Thorne heard more from Rodger MacArthur of Wayne State University in Detroit.

[audio:https://www.audiomedica.com/podcasting/global_health/070117rodger_macarthur.mp3]

You may also like...

  • Guy Collender The Challenges of Urban Sanitation: News from World Water Week 19 Oct, 2011
  • Brian Greenwood Vaccination and Global Health: USA Honours British Scientist 21 Jun, 2011
  • Physical Therapy Boosts Brain Power in Hemiplegic Cerebral Palsy—PEDIATRIC PHYSICAL THERAPY Physical Therapy Boosts Brain Power in Hemiplegic Cerebral Palsy—PEDIATRIC PHYSICAL THERAPY 1 Apr, 2018
  • Rebecca Psutka Boiling Water: No Guarantee For Safe Drinking 30 Mar, 2012
  • Previous story Telomere Length Predicts Coronary Heart Disease Risk and Statin Response
  • Next story Miscarriage Risk in Women with Low Body Mass Index
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Ibrutinib: New Frontline Standard for Chronic Lymphocytic…
    • Microbiome Diversity Key To Survival After Allogeneic…
    • New Front Line Standard for Older Patients with Chronic…
    • Which Tasks Most Influence Pediatric PT Productivity,…
    • Genomic-led AML Clinical Decision Making Within Seven Days
  • Home
  • Public Health
  • Three-Class Antiretroviral Therapy for HIV Not Appropriate: Results from the FIRST Study

© Copyright 2022 AudioMedica.com. Typegrid Theme by WPBandit.